Drugs / ARC-AAT Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02900183 | Oct → Nov 2016 | alpha 1-antitrypsin deficiency | Arrowhead Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARC-AAT Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02900183 ↗ |
| Route | Intravenous | “administered intravenously” NCT02900183 ↗ |